Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
about
Anti-vascular endothelial growth factor for proliferative diabetic retinopathyProliferative diabetic retinopathy: predictive and preventive measures at hypoxia induced retinal changes.Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.Treatment of proliferative diabetic retinopathy with anti-VEGF agents.Alterations in the intraocular cytokine milieu after intravitreal bevacizumab.Stromal cell-derived factor-1 is essential for photoreceptor cell protection in retinal detachment.Effect of intravitreal bevacizumab on vascular endothelial growth factor expression in patients with proliferative diabetic retinopathy.Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab.SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachmentElevated Levels of Cytokines Associated with Th2 and Th17 Cells in Vitreous Fluid of Proliferative Diabetic Retinopathy Patients.Larger therapeutic window for steroid versus VEGF-A inhibitor in inflammatory angiogenesis: surprisingly similar impact on leukocyte infiltration.Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections.Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.Emerging therapeutic approaches in the management of retinal angiogenesis and edema.Trends in proteomic analysis of human vitreous humor samples.Toxic effects of extracellular histones and their neutralization by vitreous in retinal detachment.Effect of bevacizumab on the expression of fibrosis-related inflammatory mediators in ARPE-19 cells.Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients.Management of diabetic macular edema in Japan: a review and expert opinion.Bevacizumab modulates the process of fibrosis in vitro.Aqueous vascular endothelial growth factor and clinical outcomes correlation after single intravitreal injection of bevacizumab in patients with neovascular age-related macular degeneration.The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment.
P2860
Q24187858-69D59E8F-D74F-4BD5-9332-FDCB48BDEBDAQ31107603-C81F22AE-70D6-4080-BBA1-2B0B4811B4E4Q33517638-FB54EA94-4002-4736-ADFD-23C529A8C497Q33812021-E685C144-0BBE-4F02-B3F4-BB5FABE3C481Q33845524-7D7E6A67-9E67-4D04-8F53-4DF0B3D76DEAQ34254392-746EA0F7-9CA0-4AF4-9EC9-F9A7C61555AAQ34474545-A802A922-DF30-4854-812E-C79803B941A9Q34958682-E2B08A4E-7D99-4282-BD6E-1AB0D06DFB92Q35085700-CB7502EC-C5A1-4FFF-8496-7957361B3F52Q35645859-B04A7491-2073-491E-9571-6F85D30DD3B1Q35768068-0A922395-F950-4772-8306-21FA34C9249BQ36065917-A52CD390-2D69-4562-99B7-7D9D855999E0Q36906893-407B2C69-9720-4C25-A637-7C0C4734DE5BQ37700035-24F2DFFB-BC6A-4C5C-8429-9D10EBFEC4F6Q37822290-6D2B54E8-7AA8-4EF5-9764-F869406BABBBQ38211623-1B1512CF-9687-4EDA-818A-DDD6E661E5D0Q39016831-159DA50A-61F0-4CB1-9067-214E82938C55Q41808036-873E9370-5531-4DB3-A628-0A731E399AE2Q43104088-F9E4E700-7775-4174-9AFE-1F46AA3FB6E8Q48579709-3FAFEE79-BEF6-480C-B316-A647067D78B9Q50453482-126647F4-EB8C-49C8-99BB-0FFE5D211686Q53315137-6B64DFB3-0360-453C-B024-CBFD2FDC9089Q53380645-18829FC1-E63F-44EA-8885-016CC6E18B52Q55007680-2BC28874-352E-423F-A9F7-401BE2BCB96A
P2860
Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Vitreous mediators after intra ...... ferative diabetic retinopathy.
@en
Vitreous mediators after intra ...... ferative diabetic retinopathy.
@nl
type
label
Vitreous mediators after intra ...... ferative diabetic retinopathy.
@en
Vitreous mediators after intra ...... ferative diabetic retinopathy.
@nl
prefLabel
Vitreous mediators after intra ...... ferative diabetic retinopathy.
@en
Vitreous mediators after intra ...... ferative diabetic retinopathy.
@nl
P2093
P1433
P1476
Vitreous mediators after intra ...... ferative diabetic retinopathy.
@en
P2093
Hiroki Otsuka
Ikuro Maruyama
Keita Yamakiri
Noboru Arimura
Shintaro Nakao
Taiji Sakamoto
Teruto Hashiguchi
Yasushi Sonoda
Yoshihiro Noda
P304
P356
10.1016/J.OPHTHA.2008.12.024
P577
2009-05-01T00:00:00Z